In Chen Yang's positioning, Andres Technology is a company involving high-tech and cutting-edge biotech. Although everything is still in its infancy, it has a starting capital of one billion US dollars. Fangye and others directly rented a three-story building in a commercial district in the city center as the company's office location.

Of course, the real research center is still in the outskirts of Los Angeles, the pharmaceutical factory that was being renovated and built.

"This is Dr. Grey Foyle, Dr. Gordon Freeman and Dr. Dargenhan Hills..."

Everyone walked into the company's conference room, and three hired doctors in biomedical science stood up together. Fang Ye quickly introduced Chen Yang.

Chen Yang stretched out his hand and shook hands with the three doctors one after another.

In fact, these three doctors were chosen by Chen Yang, so how could they not know these three people?

Dr. Grey Foyle, forty-five years old, used to work for Merck, but was later fired by the company due to a medical error. Now he is in the trough of his life. He has divorced his wife and has not obtained custody of several children. Even his personal financial situation is embarrassing.

Therefore, Andres was just a new company, but the generous reward still made Foyle agree without hesitation.

The other two Freeman and Dr. Hills have a very worrying financial situation. It is precisely because of the huge pressure of life that they have to agree to Andres' employment.

In this world, it is not to say that talents can be truly valued and their talents are used. Not to mention talents, even many geniuses have caused a series of deep regrets due to various reasons.

These three doctors all have certain talents, but unfortunately they are not very lucky. If they hadn't met Chen Yang's favourites, they might have been wasting their whole lives.

"Three doctors, I'm glad you've accepted the company's employment."

Chen Yang spoke fluent English, and everyone present could hear clearly except for the confused Wang Rui.

Sitting down in the chair, Chen Yang smiled slightly: "I know the three doctors. In fact, I am not willing to accept the company's employment in my heart. I think we are just a new company without much technology. Here, I can reveal to the three doctors that our company is not without technology, but just transforming technology into actual talents."

After saying these words, Chen Yang signaled Liu Helan with his eyes. Liu Helan nodded, took out the silver-white password box and opened it. He took out five documents and handed them to everyone present.

"This is……"

Foyle and three other doctors took the document in confusion and started to read it casually.

After only reading the content of one page, the expression on the faces changed from being careless to being serious. The speed of flipping through documents with fingers suddenly slowed down, just like a priest holding the Bible. He read almost word by word.

Chen Yang was very patient, siping the coffee on the table, waiting patiently for the reading of the three doctors, without any impatientness.

The three biomedical doctors could understand that Fang Ye and Feng Li's English was not yet well enough to browse the full range of medical terms without any obstacles. After quickly reading a few pages of content, they put down dizzyly.

Half an hour passed. The coffee was changed three times, and the three doctors finally finished reading the documents.

After reading it, Dr. Foyle asked impatiently: "Where did this information come from?"

“Where did it come from?”

Chen Yang did not mind Foyle's distrust and kept a smile and said, "I have said before that the company is not technically behind the other pharmaceutical companies. All they lack is talents like the three doctors."

His words are contradictory. Since there is a shortage of talent, where does the technology come from?

Since you have the technology, there is definitely no shortage of talents.

The three doctors only thought that Chen Yang was polite and did not take it seriously. However, according to their experience, the data is very authentic and it is almost impossible to make up randomly. They are waiting for the clinical trial to enter FDA review.

"If the information above is true, no, it is really impossible to be wrong, then the benefits are obvious."

Hills said seriously: "Everyone should know that the President's Science and Technology Advisory Committee (Pcast) has recently recommended that the government take measures to speed up the research of new antibiotics, and recommend that FDA approve this type of drug and set up a special green fast track to ensure it can be launched as soon as possible."

"In this way, we can catch up with the opportunity and get strong support from the government."

The most famous representative of antibiotics is penicillin. Since its birth in 1928, it has been nearly a century and saved the lives of thousands of people. It is famous.

However, due to the large-scale abuse of antibiotics, the resistance of some bacteria has continued to increase, resulting in many antibiotics being useless.

This situation has become increasingly intense in the past 20 years since the 1990s, making many biopharmaceutical companies less time than the time when bacterial resistance is generated, resulting in insufficient R&D costs.

This situation reached its peak in the late 1990s and early 21st century, and many biopharmaceutical giants gave up on the research and development of antibiotics.

But giving up research does not mean that bacterial resistance will not develop.

On the contrary, in recent years, many highly resistant bacteria have suddenly increased, causing many diseases that have been under control to become out of control.

For example, superbinobacterium has caused the tuberculosis control situation in many developing countries to deteriorate.

If this issue is not taken seriously, I believe that it will take many years to find that many doctors will be shocked to find that no matter how many units of antibiotics are, they will have no effect on some super resistant bacteria.

In this way, the mortality rate of humans who contract diseases will increase greatly.

Therefore, under this huge future crisis, it has also attracted the attention of the Obama administration, so this will be a very big opportunity.

Generally speaking, the faster review process of a new drug will take seven or eight months, and if it is slower, it will even take several years. This time with the support of the Washington government in the United States, whether it is speed or related costs, it will be reduced in large quantities.

These are not the most important things. If you are ahead of other biopharmaceutical companies and gain the recognition of the government, you don’t have to worry about advertising and public relations promotion.

With the support and recognition of the government, think about it, how many hospitals are there in the United States? What about the rest of the countries?

You should know that seven of the world's top ten pharmaceutical companies are in the United States. With government support, it will be more conducive to promoting new antibiotics in other countries.

Money, countless money.

Chen Yang pointed at the desktop and said, "Dr. Hills said it well, and I agree with this point, so we must seize this opportunity. The timing is urgent. We must launch our antibiotics before other pharmaceutical companies launch new antibiotics!"

Even with a cheating tool like a civilized heart and a right hand, Chen Yang did not dare to ignore those super multinational pharmaceutical companies, tens of thousands of researchers, the most advanced research equipment, the top biological talents, and the most abundant research funds. As long as they make up their minds and gather strength, there are not many difficulties that will make them difficult except for those unsolved terminal illnesses.

Therefore, it is the top priority to seize the time to produce new antibiotics and successfully pass government approval.

It is also the first step to start the name Andres.

This research data gave Hills and the other three great confidence. It was a completely different mental state. Since we knew that this new company was not simple, the three of them had a lot of peace.

Although Fang Ye and Feng Li did not understand biomedicine knowledge, Chen Yang explained clearly enough in the discussions between the three doctors, and also knew the business opportunities and potential contained in it.

As long as you grasp it, it will be a big deal.

Andres's start-up capital is only $1.2 billion, of which $500 million needs to be invested in Australia, and the North American branch is divided into $700 million.

A seemingly huge number, but in fact, it is hard to describe it as being stretched to be difficult to describe in terms of medical development, and it can only be said to be nothing.

Previously, after the pharmaceutical company "Eli Lilly" failed to invest more than one billion US dollars in developing a new drug, it invested another $500 million to continue to develop, and the success rate of the new drug was only 9%.

To buy land, land, to buy a small pharmaceutical factory, to build a few office buildings, to produce new drugs...

Chen Yang could even imagine that Fang Ye and Feng Li came together to ask for money a month later.

As for another chess piece Apocalypse Technology Company, although it is expected to make more than one billion US dollars in the next year, the earliest amount of money, at most hundreds of millions of US dollars, is far from enough.

Thinking of this, Chen Yang frowned and said, "Dr. Foyle, how much do you think this new antibiotic can reach annual sales after it is launched?"

Although Foyle is a scientist, he has also worked at Merck and has clearly known the sales and potential of some new drugs. When he heard Chen Yang's question, he lowered his head and thought for a moment, then looked up and said: "According to the information in this document, this new antibiotic has a wide range of uses, and the annual sales potential should be between more than 2 billion US dollars, and 3 billion US dollars."

Chen Yang nodded. This number is no longer a small number. For example, the well-known amoxicillin was first successfully developed by the British Bichem Company, and its annual sales in the world market are only about 1.7 billion US dollars.

If you really have annual sales of more than 2 billion US dollars, you will be the king of antibiotics.
Chapter completed!